At baseline, most patients (97%) were treated with one or more glucose-lowering medications, including metformin (76%), insulin (51%), SGLT-2i (27%), sulfonylurea (29%), and DPP-4i (23%) with CV disease and risk factors managed with lipid-lowering medications (89%), platelet-aggregation inhibitors including aspirin (77%), angiotensin converting enzyme inhibitors or angiotensin II receptor blockers (79%), and beta blockers (64%)
These include: If you or a relative has experienced any of the above after taking Ozempic, Wegovy, and Rybelsus contact us immediately
Oh, and plz take everyones reviews with a grain of salt because theyre nowhere near as reliable as a fancy clinical trial, and I wasnt a fly on the wall to witness their before-and-afterssadly
That way, the company can be sure its products contain exactly what the label states, without the risk of contaminants and heavy metals
If joint pain is persistent, it's worth seeing a healthcare professional to rule out inflammatory arthritis
BoothSLSheaMKBargerKLeurgansSEJamesBDHollandTMet al
